Epithelial mesenchymal transition and tumor budding in aggressive colorectal cancer: tumor budding as oncotarget.
about
Single Nucleotide Polymorphisms as Prognostic and Predictive Factors of Adjuvant Chemotherapy in Colorectal Cancer of Stages I and IITracking the intermediate stages of epithelial-mesenchymal transition in epithelial stem cells and cancerMetastatic cancer stem cells: from the concept to therapeuticsEmerging roles of PDGF-D in EMT progression during tumorigenesisMolecular and pathogenetic aspects of tumor budding in colorectal cancerFGF receptors: cancer biology and therapeuticsMicroRNA-200b is downregulated in colon cancer budding cells.Controversies in the pathological assessment of colorectal cancerEMT transcription factors snail and slug directly contribute to cisplatin resistance in ovarian cancerTumor budding as a risk factor of lymph node metastasis in submucosal invasive T1 colorectal carcinoma: a retrospective study.Tumor budding is associated with an increased risk of lymph node metastasis and poor prognosis in superficial esophageal adenocarcinoma.Histopathological features predict metastatic potential in locally advanced colon carcinomasImplications of epithelial-mesenchymal plasticity for heterogeneity in colorectal cancer.Widespread FRA1-dependent control of mesenchymal transdifferentiation programs in colorectal cancer cells.TWIST1 and TWIST2 promoter methylation and protein expression in tumor stroma influence the epithelial-mesenchymal transition-like tumor budding phenotype in colorectal cancerHigh tumor budding stratifies breast cancer with metastatic properties.Heterogeneity analysis of Metastasis Associated in Colon Cancer 1 (MACC1) for survival prognosis of colorectal cancer patients: a retrospective cohort study.Accumulation of FOXP3+T-cells in the tumor microenvironment is associated with an epithelial-mesenchymal-transition-type tumor budding phenotype and is an independent prognostic factor in surgically resected pancreatic ductal adenocarcinomaCell type- and tumor zone-specific expression of pVEGFR-1 and its ligands influence colon cancer metastasis.Targeting invadopodia to block breast cancer metastasisTumor budding in colorectal carcinoma assessed by cytokeratin immunostaining and budding areas: possible involvement of c-Met.Combined evaluation of hexokinase 2 and phosphorylated pyruvate dehydrogenase-E1α in invasive front lesions of colorectal tumors predicts cancer metabolism and patient prognosis.Recent progress in targeting cancer.Norepinephrine induced epithelial-mesenchymal transition in HT-29 and A549 cells in vitro.Molecular events in primary and metastatic colorectal carcinoma: a review.Proteomic signatures of the desmoplastic invasion front reveal collagen type XII as a marker of myofibroblastic differentiation during colorectal cancer metastasis.Expressions of matrix metalloproteinase-9 (MMP-9), dentin sialophosphoprotein (DSPP), and osteopontin (OPN) at histologically negative surgical margins may predict recurrence of oral squamous cell carcinomaVimentin contributes to epithelial-mesenchymal transition cancer cell mechanics by mediating cytoskeletal organization and focal adhesion maturation.TAZ induces growth factor-independent proliferation through activation of EGFR ligand amphiregulin.High-Grade Tumor Budding Stratifies Early-Stage Cervical Cancer with Recurrence RiskExpression profiling of budding cells in colorectal cancer reveals an EMT-like phenotype and molecular subtype switching.Absence of myeloperoxidase and CD8 positive cells in colorectal cancer infiltrates identifies patients with severe prognosis.The relationship between tumour budding, the tumour microenvironment and survival in patients with invasive ductal breast cancerTumor budding and laminin5-γ2 in squamous cell carcinoma of the external auditory canal are associated with shorter survivalMolecular mechanisms underlying the antitumor activity of (E)-N-hydroxy-3-(1-(4-methoxyphenylsulfonyl)-1,2,3,4-tetrahydroquinolin-6-yl)acrylamide in human colorectal cancer cells in vitro and in vivo.DAPK loss in colon cancer tumor buds: implications for migration capacity of disseminating tumor cells.Cell budding from normal appearing epithelia: a predictor of colorectal cancer metastasis?Management of stage II colon cancer - the use of molecular biomarkers for adjuvant therapy decision.ASF-4-1 fibroblast-rich culture increases chemoresistance and mTOR expression of pancreatic cancer BxPC-3 cells at the invasive front in vitro, and promotes tumor growth and invasion in vivo.Tumour budding with and without admixed inflammation: two different sides of the same coin?
P2860
Q26765344-13FD3AE5-EACA-4867-BA62-90C97688E316Q26829478-99D6AEC5-CF0F-4F76-83E8-A94127618BFDQ26850739-7B6F205C-3BD7-4BB8-B9D1-418292BF279CQ26859634-55E4B7D4-91E1-4499-9090-29FBA3EC6721Q28085313-0F8A971C-5A06-46E0-98F0-4E056202D0FCQ28291186-FC190D88-B477-46F5-88A8-70C8127CA5F3Q33732204-184E318D-9360-4842-A113-6D1E05A9B8CBQ34008807-3F267F19-5A47-4D39-BB69-D534772431DFQ34202046-C4759131-6DB2-4885-911E-46FCFF509B5CQ34367365-E5A57EC0-13CE-4EE5-BB52-3151B3A12C23Q34403203-CF019CE5-14E2-4834-A023-1DC157777D5BQ35016109-111DD794-DA52-4EDB-A1AD-73AAEF680CD5Q35037258-198AF878-6EB4-44F1-8D17-08A6041FF898Q35128358-9BF82F22-CE18-4374-83EB-F95006624141Q35176169-9949DA55-A445-411A-934F-339CD938299CQ35203546-7B51B42A-2301-4EAA-B679-DD7B86157B08Q35211652-F5672838-BAFD-4F30-B69E-5175D3D25F95Q35551974-2550A35A-99D9-4C7E-9708-C08C4B2E9B45Q35603983-F1DBBA00-C346-4DD4-A850-4E44733A6318Q35640216-B7A67039-1CF8-4C5D-8785-8DC7FDCB00FDQ35713396-AC212141-6E9D-413E-8DEE-3DAB2FA390B1Q35713627-5DC6789B-3629-42C8-B80E-69EF83FACC8CQ35740782-80571678-7765-4906-BD6A-F1D1BBC0ADBFQ35769839-DB8B2650-2DD9-4D5D-99D3-DD03105A377AQ35977849-FA11FCE2-5498-438F-8F6D-A347520D1326Q35987073-AF06F8F2-D9C8-4656-9A14-ABEF23D2B309Q35987076-4397DA4A-3302-4BCD-937F-0B22F7A07759Q36140688-ADBB37E3-4469-4692-B721-EEC6C74F15AAQ36164116-141838CB-29B6-4CDD-970F-CD1DEB5BBF1AQ36197182-56056546-8196-40DC-B112-5C1793FA9929Q36203396-30C371E3-78C1-4BA6-8960-D19A890E9CC2Q36255726-F1FD4529-EA47-40F2-8DFC-116A1F38F2E8Q36295024-B57A2235-A3DD-474E-938D-434BFEBB4C92Q36403343-CEF6A437-0DB9-4A73-A155-24F415BC6F00Q36546534-6381C75C-4582-4920-994D-DE1019F3D1C6Q36546788-7179E2B3-6F6E-49D7-887D-6A5F690D967FQ36562747-97FA41E0-028A-431A-8718-1FDDF7BC3881Q36688767-EC39BBE3-4300-438A-9454-503DEA2DB3C9Q36742326-438BFD54-5A17-4A3B-9A59-3B2593D08DB0Q36750548-65ABA862-50B2-4C25-A839-B0B684CB3977
P2860
Epithelial mesenchymal transition and tumor budding in aggressive colorectal cancer: tumor budding as oncotarget.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Epithelial mesenchymal transit ...... : tumor budding as oncotarget.
@en
Epithelial mesenchymal transit ...... : tumor budding as oncotarget.
@nl
type
label
Epithelial mesenchymal transit ...... : tumor budding as oncotarget.
@en
Epithelial mesenchymal transit ...... : tumor budding as oncotarget.
@nl
prefLabel
Epithelial mesenchymal transit ...... : tumor budding as oncotarget.
@en
Epithelial mesenchymal transit ...... : tumor budding as oncotarget.
@nl
P2860
P921
P356
P1433
P1476
Epithelial mesenchymal transit ...... : tumor budding as oncotarget.
@en
P2093
Alessandro Lugli
P2860
P304
P356
10.18632/ONCOTARGET.199
P407
P50
P5008
P577
2010-11-01T00:00:00Z